These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11936358)

  • 1. Guidelines on antimicrobial chemotherapy for prevention and treatment of infections in the intensive care unit.
    Bergogne-Bérézin E
    J Chemother; 2001 Nov; 13 Spec No 1(1):134-49. PubMed ID: 11936358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current guidelines for the treatment and prevention of nosocomial infections.
    Bergogne-Bérézin E
    Drugs; 1999 Jul; 58(1):51-67. PubMed ID: 10439929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward.
    Hughes MG; Evans HL; Chong TW; Smith RL; Raymond DP; Pelletier SJ; Pruett TL; Sawyer RG
    Crit Care Med; 2004 Jan; 32(1):53-60. PubMed ID: 14707559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic resistance in the intensive care unit.
    Kollef MH; Fraser VJ
    Ann Intern Med; 2001 Feb; 134(4):298-314. PubMed ID: 11182841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current guidelines for the treatment of severe pneumonia and sepsis.
    Bodmann KF
    Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs.
    Geissler A; Gerbeaux P; Granier I; Blanc P; Facon K; Durand-Gasselin J
    Intensive Care Med; 2003 Jan; 29(1):49-54. PubMed ID: 12528022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Can one use probabilistic protocols for antibiotic therapy in intensive care units?].
    Bourdain N; Lepape A; Galzot F; Lamy B; Haessler D; Chomarat M; Grozel JM; Banssillon V
    Pathol Biol (Paris); 1999 May; 47(5):584-8. PubMed ID: 10418047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of antibiotic resistance in European ICUs.
    Hanberger H; Diekema D; Fluit A; Jones R; Struelens M; Spencer R; Wolff M
    J Hosp Infect; 2001 Jul; 48(3):161-76. PubMed ID: 11439002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic-resistant infections in the critically ill adult.
    Silveira F; Fujitani S; Paterson DL
    Clin Lab Med; 2004 Jun; 24(2):329-41. PubMed ID: 15177843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Strategies in the treatment of infections with antibiotics in intensive care medicine].
    Deja M; Nachtigall I; Halle E; Kastrup M; Guill MM; Spies CD
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Feb; 42(2):108-15. PubMed ID: 17309018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nosocomial infections due to antibiotic-resistant organisms on length of stay and mortality in the pediatric intensive care unit.
    Foglia EE; Fraser VJ; Elward AM
    Infect Control Hosp Epidemiol; 2007 Mar; 28(3):299-306. PubMed ID: 17326020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance: factors and outcomes.
    Fish DN; Ohlinger MJ
    Crit Care Clin; 2006 Apr; 22(2):291-311, vii. PubMed ID: 16678001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacteriologic and clinical analysis of nosocomial infections in patients from the intensive care unit].
    Nikodemski T
    Ann Acad Med Stetin; 1999; 45():211-26. PubMed ID: 10909491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients.
    Kollef MH
    Clin Infect Dis; 2000 Sep; 31 Suppl 4():S131-8. PubMed ID: 11017862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations in the choice and administration of agents for empiric antimicrobial therapy.
    Baughman RP
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-71-82. PubMed ID: 23577498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of susceptibility to beta-lactam antimicrobial agents among bacteria isolated from intensive care units.
    Pierson CL; Friedman BA
    Diagn Microbiol Infect Dis; 1992 Feb; 15(2 Suppl):19S-30S. PubMed ID: 1737439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The drug resistance of pathogenic bacteria of nosocomial infections in surgical intensive care unit].
    Chen J; Li LF; Guan XD; Chen DM; Chen MY; Ouyang B; Huang SW; Wu JF
    Zhonghua Wai Ke Za Zhi; 2006 Sep; 44(17):1189-92. PubMed ID: 17147864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for ICU-acquired imipenem-resistant Gram-negative bacterial infections.
    Akinci E; Colpan A; Bodur H; Balaban N; Erbay A
    J Hosp Infect; 2005 Apr; 59(4):317-23. PubMed ID: 15749320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.